I would say, that’s partially offset by some trailing losses. That’s having maybe a couple of points – a point or so of impact. And then we’ve got a point or two of impact the benefits of the new wins that are coming into place right now. And we expect that just to continue with momentum. But you’re right, Eric, is really pleased with the way the revenue growth in Medical Distribution sales is going, the flat – the 5% growth, just overall regardless of all the noise in the system is really a testament to what the commercial team has done, as well as what we’ve done from going out and driving significant operational improvements relative to what historically has been there for bus [ph] and others in the industry.
Eric Coldwell: When you cite additional services, could you give us a sense of what you’re talking about there? Would that be things like kitting programs? stocking as a service. I mean, is there any kind of additional color that you could provide on the additional services opportunities?
Alexander Bruni: Yes, some of the stuff – like I’ll give you an example, is outsourced logistics. So you may have a device company or another manufacturer that’s looking for the outsourcing logistics and being able to get the product into the hospital. That’s one example of where we started. We’re seeing growth is in our outsourced logistics business. So that’s – I just use that as a single example, but that’s an example of a service where we’re doing that. And we are – we’ve spent a tremendous amount of time in our kitting business since you did raise that with our leadership in the operations have spent a tremendous amount of time really looking at how do we eliminate cost as well as waste in there and improve service. And we’ve increased now our service levels to close to 100% of being able to manufacture and get kits out on time.
And all that’s done right now in the U.S. So from a service level, it has the ability to get it to the customers quicker. That’s another example of some of the stuff that we’re focused on.
Eric Coldwell: And then if I might. What’s the – in distribution, just core acute care, I guess, as well as any alternate site comments. But what is the landscape for the new business environment today? Is the market – is there a churn out there? I mean, we’ve heard it stabilizing and there’s not as much, but what are you seeing in terms of RFPs or customers maybe vetting other vendors? Just big picture on churn and pipeline expectations?
Alexander Bruni: Yes. So we’ve seen some big chunky ones that are out right now where there’s opportunity and where we’re also in a retention position. The good news is the bulk of our top 10, we renewed for extended periods of time. I think that was critical to us. But we are seeing a mix right now in some of the large bulky ones or large ones. But then also, I think that we’re also – there’s also the mid and small-sized customers that are looking for different ways to have a higher level of service as well as competitive pricing out there. Our pipeline is still strong. We’ve got a very large pipeline. And if you just think about it an average, if an average customer is a 3- to 5-year contract, our pipeline should be $1 billion plus – $2 billion plus at any time as we’re looking to – as we’re looking to find opportunities to win business.
